Synthesis, docking molecule study and antibacterial activity of N’-(4-Fluorobenzylidene)-4-hydroxybenzohydrazide and N’-(4-Fluorobenzylidene)-4-hydroxybenzohydrazide)

Suzana, - and Melanny Ika Sulistyowati, - and Isnaeni, - and Tutuk Budiati, - (2019) Synthesis, docking molecule study and antibacterial activity of N’-(4-Fluorobenzylidene)-4-hydroxybenzohydrazide and N’-(4-Fluorobenzylidene)-4-hydroxybenzohydrazide). Journal of Physics: Conference Series, 1146. pp. 1-7. ISSN 1742-6596

[img] Text (FULLTEXT)
C-06 Artikel.pdf

Download (1MB)
[img] Text (PEER REVIEW)
c6.pdf

Download (1MB)
[img] Text (SIMILARITY)
C-06 Similarity.pdf

Download (2MB)
Official URL: https://iopscience.iop.org/article/10.1088/1742-65...

Abstract

Many antibacterial are already resistant, so new antibacterial is needed. Objective:The compounds of N'- (4-Fluorobenzylidene) -4-hydroxybenzohydrazide, and N' - (3-Bromobenzylidene) -4-hydroxybenzohydrazide as antibacterial generally contain azometin (HN-N=CH-) and halogen groups. Before the compounds to be synthesized were done docking molecule study, to predict its activity as antibacterial. The synthesis was carried out by microwave and identification of the results with FT-IR, MS, 1H-NMR, and 13C-NMR, docking molecule study with the Molegro Virtual Docker program, and antibacterial activity by diffusion method. The obtained compounds of N '- (4-Fluorobenzylidene) -4-hydroxybenzohydrazide, and N' - (3-Bromobenzylidene) -4-hydroxybenzohydrazide 87%, and 81% yield respectively. The results of docking molecule study obtained reranked score lower than the starting material (methyl 4-hydroxybenzoate). The compounds have antibacterial activity against Gram positive (Bacillus subtilis) and Gram negative (Escherichia coli). Conclusion: N '- (4-Fluorobenzylidene) -4-hydroxybenzohydrazide and N' - (3-Bromobenzylidene) -4-hydroxybenzohydrazide have been synthesized, characterized and exhibited promised antibacterial.

Item Type: Article
Subjects: R Medicine
R Medicine > RS Pharmacy and materia medica
R Medicine > RS Pharmacy and materia medica > RS1-441 Pharmacy and materia medica
R Medicine > RS Pharmacy and materia medica > RS200-201 Pharmaceutical dosage forms
Creators:
CreatorsNIM
Suzana, -NIDN0027096504
Melanny Ika Sulistyowati, -NIDN0005058201
Isnaeni, -NIDN0013015603
Tutuk Budiati, --
Depositing User: Mr M. Fuad Sofyan
Date Deposited: 21 Sep 2021 04:22
Last Modified: 22 Dec 2021 00:40
URI: http://repository.unair.ac.id/id/eprint/109979
Sosial Share:

Actions (login required)

View Item View Item